{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:39:32Z","timestamp":1790743172917,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2009,2,23]],"date-time":"2009-02-23T00:00:00Z","timestamp":1235347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,2,23]],"date-time":"2009-02-23T00:00:00Z","timestamp":1235347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2009,4,2]]},"DOI":"10.1038\/onc.2009.14","type":"journal-article","created":{"date-parts":[[2009,2,23]],"date-time":"2009-02-23T07:55:37Z","timestamp":1235375737000},"page":"1594-1604","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":198,"title":["The role of the Birt\u2013Hogg\u2013Dub\u00e9 protein in mTOR activation and renal tumorigenesis"],"prefix":"10.1038","volume":"28","author":[{"given":"T R","family":"Hartman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Klein-Szanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Al-Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T P","family":"Cash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M C","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E P","family":"Henske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,23]]},"reference":[{"key":"BFonc200914_CR1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/jnci\/djm288","volume":"100","author":"M Baba","year":"2008","unstructured":"Baba M, Furihata M, Hong SB, Tessarollo L, Haines DC, Southon E et al. (2008). Kidney-targeted Birt\u2013Hogg\u2013Dube gene inactivation in a mouse model: Erk1\/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys. J Natl Cancer Inst 100: 140\u2013154.","journal-title":"J Natl Cancer Inst"},{"key":"BFonc200914_CR2","doi-asserted-by":"publisher","first-page":"15552","DOI":"10.1073\/pnas.0603781103","volume":"103","author":"M Baba","year":"2006","unstructured":"Baba M, Hong SB, Sharma N, Warren MB, Nickerson ML, Iwamatsu A et al. (2006). Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Proc Natl Acad Sci USA 103: 15552\u201315557.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc200914_CR3","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/carcin\/21.7.1379","volume":"21","author":"JT Babbitt","year":"2000","unstructured":"Babbitt JT, Kharazi AI, Taylor JM, Bonds CB, Mirell SG, Frumkin E et al. (2000). Hematopoietic neoplasia in C57BL\/6 mice exposed to split-dose ionizing radiation and circularly polarized 60 Hz magnetic fields. Carcinogenesis 21: 1379\u20131389.","journal-title":"Carcinogenesis"},{"key":"BFonc200914_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1073\/pnas.0409143102","volume":"102","author":"BA Ballif","year":"2005","unstructured":"Ballif BA, Roux PP, Gerber SA, MacKeigan JP, Blenis J, Gygi SP . (2005). Quantitative phosphorylation profiling of the ERK\/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors. Proc Natl Acad Sci USA 102: 667\u2013672.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc200914_CR5","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/0090-4295(78)90434-X","volume":"12","author":"GL Barbour","year":"1978","unstructured":"Barbour GL, Casali RE . (1978). Bilateral angiomyolipomas and renal cell carcinoma in polycystic kidney. Urology 12: 694\u2013698.","journal-title":"Urology"},{"key":"BFonc200914_CR6","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1001\/archderm.1977.01640120042005","volume":"113","author":"AR Birt","year":"1977","unstructured":"Birt AR, Hogg GR, Dube WJ . (1977). Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol 113: 1674\u20131677.","journal-title":"Arch Dermatol"},{"key":"BFonc200914_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1083\/jcb.200507119","volume":"173","author":"SL Cai","year":"2006","unstructured":"Cai SL, Tee AR, Short JD, Bergeron JM, Kim J, Shen J et al. (2006). Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. J Cell Biol 173: 279\u2013289.","journal-title":"J Cell Biol"},{"key":"BFonc200914_CR8","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","volume":"97","author":"T Carsillo","year":"2000","unstructured":"Carsillo T, Astrinidis A, Henske EP . (2000). Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci USA 97: 6085\u20136090.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc200914_CR9","doi-asserted-by":"publisher","first-page":"32493","DOI":"10.1074\/jbc.C300226200","volume":"278","author":"AF Castro","year":"2003","unstructured":"Castro AF, Rebhun JF, Clark GJ, Quilliam LA . (2003). Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner. J Biol Chem 278: 32493\u201332496.","journal-title":"J Biol Chem"},{"key":"BFonc200914_CR10","doi-asserted-by":"publisher","first-page":"e3581","DOI":"10.1371\/journal.pone.0003581","volume":"3","author":"J Chen","year":"2008","unstructured":"Chen J, Futami K, Petillo D, Peng J, Wang P, Knol J et al. (2008). Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia. PLoS ONE 3: e3581.","journal-title":"PLoS ONE"},{"key":"BFonc200914_CR11","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"PB Crino","year":"2006","unstructured":"Crino PB, Nathanson KL, Henske EP . (2006). The tuberous sclerosis complex. N Engl J Med 355: 1345\u20131356.","journal-title":"N Engl J Med"},{"key":"BFonc200914_CR12","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","volume":"75","author":"European Chromosome 16 Tuberous Sclerosis Consortium","year":"1993","unstructured":"European Chromosome 16 Tuberous Sclerosis Consortium (1993). Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75: 1305\u20131315.","journal-title":"Cell"},{"key":"BFonc200914_CR13","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S1097-2765(03)00220-X","volume":"11","author":"A Garami","year":"2003","unstructured":"Garami A, Zwartkruis FJ, Nobukuni T, Joaquin M, Roccio M, Stocker H et al. (2003). Insulin activation of Rheb, a mediator of mTOR\/S6K\/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell 11: 1457\u20131466.","journal-title":"Mol Cell"},{"key":"BFonc200914_CR14","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1096\/fasebj.7.10.8344491","volume":"7","author":"M Harvey","year":"1993","unstructured":"Harvey M, McArthur MJ, Montgomery Jr CA, Bradley A, Donehower LA . (1993). Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J 7: 938\u2013943.","journal-title":"FASEB J"},{"key":"BFonc200914_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.gene.2008.02.022","volume":"415","author":"H Hasumi","year":"2008","unstructured":"Hasumi H, Baba M, Hong SB, Hasumi Y, Huang Y, Yao M et al. (2008). Identification and characterization of a novel folliculin-interacting protein FNIP2. Gene 415: 60\u201367.","journal-title":"Gene"},{"key":"BFonc200914_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/gcc.2870130411","volume":"13","author":"EP Henske","year":"1995","unstructured":"Henske EP, Neumann HP, Scheithauer BW, Herbst EW, Short MP, Kwiatkowski DJ . (1995). Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes Cancer 13: 295\u2013298.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFonc200914_CR17","first-page":"400","volume":"59","author":"EP Henske","year":"1996","unstructured":"Henske EP, Scheithauer BW, Short MP, Wollmann R, Nahmias J, Hornigold N et al. (1996). Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet 59: 400\u2013406.","journal-title":"Am J Hum Genet"},{"key":"BFonc200914_CR18","first-page":"5856","volume":"53","author":"O Hino","year":"1993","unstructured":"Hino O, Mitani H, Knudson AG . (1993). Genetic predisposition to transplacentally induced renal cell carcinomas in the Eker rat. Cancer Res 53: 5856\u20135858.","journal-title":"Cancer Res"},{"key":"BFonc200914_CR19","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/j.1349-7006.2001.tb02133.x","volume":"92","author":"O Hino","year":"2001","unstructured":"Hino O, Okimoto K, Kouchi M, Sakurai J . (2001). A novel renal carcinoma predisposing gene of the Nihon rat maps on chromosome 10. Jpn J Cancer Res 92: 1147\u20131149.","journal-title":"Jpn J Cancer Res"},{"key":"BFonc200914_CR20","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1101\/gad.1110003","volume":"17","author":"K Inoki","year":"2003","unstructured":"Inoki K, Li Y, Xu T, Guan KL . (2003). Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 17: 1829\u20131834.","journal-title":"Genes Dev"},{"key":"BFonc200914_CR21","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1136\/jmg.39.12.906","volume":"39","author":"SK Khoo","year":"2002","unstructured":"Khoo SK, Giraud S, Kahnoski K, Chen J, Motorna O, Nickolov R et al. (2002). Clinical and genetic studies of Birt\u2013Hogg\u2013Dube syndrome. J Med Genet 39: 906\u2013912.","journal-title":"J Med Genet"},{"key":"BFonc200914_CR22","first-page":"1206","volume":"59","author":"T Kobayashi","year":"1999","unstructured":"Kobayashi T, Minowa O, Kuno J, Mitani H, Hino O, Noda T . (1999). Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice. Cancer Res 59: 1206\u20131211.","journal-title":"Cancer Res"},{"key":"BFonc200914_CR23","doi-asserted-by":"publisher","first-page":"8762","DOI":"10.1073\/pnas.151033798","volume":"98","author":"T Kobayashi","year":"2001","unstructured":"Kobayashi T, Minowa O, Sugitani Y, Takai S, Mitani H, Kobayashi E et al. (2001). A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice. Proc Natl Acad Sci USA 98: 8762\u20138767.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc200914_CR24","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00428-005-0142-9","volume":"448","author":"M Kouchi","year":"2006","unstructured":"Kouchi M, Okimoto K, Matsumoto I, Tanaka K, Yasuba M, Hino O . (2006). Natural history of the Nihon (Bhd gene mutant) rat, a novel model for human Birt\u2013Hogg\u2013Dube syndrome. Virchows Arch 448: 463\u2013471.","journal-title":"Virchows Arch"},{"key":"BFonc200914_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/sj.jid.5700959","volume":"128","author":"EM Leter","year":"2008","unstructured":"Leter EM, Koopmans AK, Gille JJ, van Os TA, Vittoz GG, David EF et al. (2008). Birt\u2013Hogg\u2013Dube syndrome: clinical and genetic studies of 20 families. J Invest Dermatol 128: 45\u201349.","journal-title":"J Invest Dermatol"},{"key":"BFonc200914_CR26","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1093\/hmg\/ddg336","volume":"12","author":"F Lingaas","year":"2003","unstructured":"Lingaas F, Comstock KE, Kirkness EF, Sorensen A, Aarskaug T, Hitte C et al. (2003). A mutation in the canine BHD gene is associated with hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis in the German Shepherd dog. Hum Mol Genet 12: 3043\u20133053.","journal-title":"Hum Mol Genet"},{"key":"BFonc200914_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cell.2005.02.031","volume":"121","author":"L Ma","year":"2005","unstructured":"Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP . (2005). Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121: 179\u2013193.","journal-title":"Cell"},{"key":"BFonc200914_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","volume":"10","author":"BD Manning","year":"2002","unstructured":"Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC . (2002). Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway. Mol Cell 10: 151\u2013162.","journal-title":"Mol Cell"},{"key":"BFonc200914_CR29","volume-title":"Pathobiology of the Aging Mouse","author":"U Mohr","year":"1996","unstructured":"Mohr U, Dungworth DL, Capen CC, Carlton WW, Sundberg JP, Ward JM . (1996). Pathobiology of the Aging Mouse, vol. 1. International Life Sciences Institute: Washington, DC, 527pp."},{"key":"BFonc200914_CR30","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/path.2139","volume":"211","author":"T Murakami","year":"2007","unstructured":"Murakami T, Sano F, Huang Y, Komiya A, Baba M, Osada Y et al. (2007). Identification and characterization of Birt\u2013Hogg\u2013Dube associated renal carcinoma. J Pathol 211: 524\u2013531.","journal-title":"J Pathol"},{"key":"BFonc200914_CR31","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/ijc.11694","volume":"109","author":"A Nagy","year":"2004","unstructured":"Nagy A, Zoubakov D, Stupar Z, Kovacs G . (2004). Lack of mutation of the folliculin gene in sporadic chromophobe renal cell carcinoma and renal oncocytoma. Int J Cancer 109: 472\u2013475.","journal-title":"Int J Cancer"},{"key":"BFonc200914_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1535-6108(02)00104-6","volume":"2","author":"ML Nickerson","year":"2002","unstructured":"Nickerson ML, Warren MB, Toro JR, Matrosova V, Glenn G, Turner ML et al. (2002). Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt\u2013Hogg\u2013Dube syndrome. Cancer Cell 2: 157\u2013164.","journal-title":"Cancer Cell"},{"key":"BFonc200914_CR33","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/S0140-6736(05)78872-3","volume":"351","author":"FJK O\u2019Callaghan","year":"1998","unstructured":"O\u2019Callaghan FJK, Shiell AW, Osborne JP, Martyn CN . (1998). Prevalence of tuberous sclerosis estimated by capture-recapture analysis. Lancet 351: 1490.","journal-title":"Lancet"},{"key":"BFonc200914_CR34","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2174\/1566524043359737","volume":"4","author":"K Okimoto","year":"2004","unstructured":"Okimoto K, Kouchi M, Matsumoto I, Sakurai J, Kobayashi T, Hino O . (2004a). Natural history of the Nihon rat model of BHD. Curr Mol Med 4: 887\u2013893.","journal-title":"Curr Mol Med"},{"key":"BFonc200914_CR35","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1073\/pnas.0308071100","volume":"101","author":"K Okimoto","year":"2004","unstructured":"Okimoto K, Sakurai J, Kobayashi T, Mitani H, Hirayama Y, Nickerson ML et al. (2004b). A germ-line insertion in the Birt\u2013Hogg\u2013Dube (BHD) gene gives rise to the Nihon rat model of inherited renal cancer. Proc Natl Acad Sci USA 101: 2023\u20132027.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc200914_CR36","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1086\/428455","volume":"76","author":"JN Painter","year":"2005","unstructured":"Painter JN, Tapanainen H, Somer M, Tukiainen P, Aittomaki K . (2005). A 4-bp deletion in the Birt\u2013Hogg\u2013Dube gene (FLCN) causes dominantly inherited spontaneous pneumothorax. Am J Hum Genet 76: 522\u2013527.","journal-title":"Am J Hum Genet"},{"key":"BFonc200914_CR37","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1097\/01.ju.0000154629.45832.30","volume":"173","author":"CP Pavlovich","year":"2005","unstructured":"Pavlovich CP, Grubb III RL, Hurley K, Glenn GM, Toro J, Schmidt LS et al. (2005). Evaluation and management of renal tumors in the Birt\u2013Hogg\u2013Dube syndrome. J Urol 173: 1482\u20131486.","journal-title":"J Urol"},{"key":"BFonc200914_CR38","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1097\/00000478-200212000-00002","volume":"26","author":"CP Pavlovich","year":"2002","unstructured":"Pavlovich CP, Walther MM, Eyler RA, Hewitt SM, Zbar B, Linehan WM et al. (2002). Renal tumors in the Birt\u2013Hogg\u2013Dube syndrome. Am J Surg Pathol 26: 1542\u20131552.","journal-title":"Am J Surg Pathol"},{"key":"BFonc200914_CR39","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.juro.2006.08.076","volume":"177","author":"VA Robb","year":"2007","unstructured":"Robb VA, Karbowniczek M, Klein-Szanto AJ, Henske EP . (2007). Activation of the mTOR signaling pathway in renal clear cell carcinoma. J Urol 177: 346\u2013352.","journal-title":"J Urol"},{"key":"BFonc200914_CR40","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1042\/BJ20041888","volume":"388","author":"M Rolfe","year":"2005","unstructured":"Rolfe M, McLeod LE, Pratt PF, Proud CG . (2005). Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2). Biochem J 388: 973\u2013984.","journal-title":"Biochem J"},{"key":"BFonc200914_CR41","doi-asserted-by":"publisher","first-page":"13489","DOI":"10.1073\/pnas.0405659101","volume":"101","author":"PP Roux","year":"2004","unstructured":"Roux PP, Ballif BA, Anjum R, Gygi SP, Blenis J . (2004). Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc Natl Acad Sci USA 101: 13489\u201313494.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc200914_CR42","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/ncb996","volume":"5","author":"LJ Saucedo","year":"2003","unstructured":"Saucedo LJ, Gao X, Chiarelli DA, Li L, Pan D, Edgar BA . (2003). Rheb promotes cell growth as a component of the insulin\/TOR signalling network. Nat Cell Biol 5: 566\u2013571.","journal-title":"Nat Cell Biol"},{"key":"BFonc200914_CR43","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1086\/430842","volume":"76","author":"LS Schmidt","year":"2005","unstructured":"Schmidt LS, Nickerson ML, Warren MB, Glenn GM, Toro JR, Merino MJ et al. (2005). Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt\u2013Hogg\u2013Dube syndrome. Am J Hum Genet 76: 1023\u20131033.","journal-title":"Am J Hum Genet"},{"key":"BFonc200914_CR44","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1086\/301804","volume":"62","author":"TA Smolarek","year":"1998","unstructured":"Smolarek TA, Wessner LL, McCormack FX, Mylet JC, Menon AG, Henske EP . (1998). Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. Am J Hum Genet 62: 810\u2013815.","journal-title":"Am J Hum Genet"},{"key":"BFonc200914_CR45","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/ncb995","volume":"5","author":"H Stocker","year":"2003","unstructured":"Stocker H, Radimerski T, Schindelholz B, Wittwer F, Belawat P, Daram P et al. (2003). Rheb is an essential regulator of S6K in controlling cell growth in Drosophila. Nat Cell Biol 5: 559\u2013565.","journal-title":"Nat Cell Biol"},{"key":"BFonc200914_CR46","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0065-230X(08)60179-7","volume":"22","author":"O Stutman","year":"1975","unstructured":"Stutman O . (1975). Immunodepression and malignancy. Adv Cancer Res 22: 261\u2013422.","journal-title":"Adv Cancer Res"},{"key":"BFonc200914_CR47","doi-asserted-by":"publisher","first-page":"5339","DOI":"10.1038\/onc.2008.261","volume":"27","author":"Y Takagi","year":"2008","unstructured":"Takagi Y, Kobayashi T, Shiono M, Wang L, Piao X, Sun G et al. (2008). Interaction of folliculin (Birt\u2013Hogg\u2013Dube gene product) with a novel Fnip1-like (FnipL\/Fnip2) protein. Oncogene 27: 5339\u20135347.","journal-title":"Oncogene"},{"key":"BFonc200914_CR48","doi-asserted-by":"publisher","first-page":"37288","DOI":"10.1074\/jbc.M303257200","volume":"278","author":"AR Tee","year":"2003","unstructured":"Tee AR, Anjum R, Blenis J . (2003a). Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase\/Akt-dependent and -independent phosphorylation of tuberin. J Biol Chem 278: 37288\u201337296.","journal-title":"J Biol Chem"},{"key":"BFonc200914_CR49","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0960-9822(03)00506-2","volume":"13","author":"AR Tee","year":"2003","unstructured":"Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J . (2003b). Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol 13: 1259\u20131268.","journal-title":"Curr Biol"},{"key":"BFonc200914_CR50","first-page":"1195","volume":"135","author":"JR Toro","year":"1999","unstructured":"Toro JR, Glenn G, Duray P, Darling T, Weirich G, Zbar B et al. (1999). Birt\u2013Hogg\u2013Dube syndrome: a novel marker of kidney neoplasia. Arch Dermatol 135: 1195\u20131202.","journal-title":"Arch Dermatol"},{"key":"BFonc200914_CR51","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00005792-199909000-00004","volume":"78","author":"T Urban","year":"1999","unstructured":"Urban T, Lazor R, Lacronique J, Murris M, Labrune S, Valeyre D et al. (1999). Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d\u2019Etudes et de Recherche sur les Maladies \u2018Orphelines\u2019 Pulmonaires (GERM\u2018O\u2019P). Medicine (Baltimore) 78: 321\u2013337.","journal-title":"Medicine (Baltimore)"},{"key":"BFonc200914_CR52","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.277.5327.805","volume":"277","author":"M van Slegtenhorst","year":"1997","unstructured":"van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S et al. (1997). Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277: 805\u2013808.","journal-title":"Science"},{"key":"BFonc200914_CR53","doi-asserted-by":"publisher","first-page":"24583","DOI":"10.1074\/jbc.M700857200","volume":"282","author":"M van Slegtenhorst","year":"2007","unstructured":"van Slegtenhorst M, Khabibullin D, Hartman TR, Nicolas E, Kruger WD, Henske EP . (2007). The Birt\u2013Hogg\u2013Dube and tuberous sclerosis complex homologs have opposing roles in amino acid homeostasis in Schizosaccharomyces pombe. J Biol Chem 282: 24583\u201324590.","journal-title":"J Biol Chem"},{"key":"BFonc200914_CR54","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1093\/jnci\/dji154","volume":"97","author":"CD Vocke","year":"2005","unstructured":"Vocke CD, Yang Y, Pavlovich CP, Schmidt LS, Nickerson ML, Torres-Cabala CA et al. (2005). High frequency of somatic frameshift BHD gene mutations in Birt\u2013Hogg\u2013Dube-associated renal tumors. J Natl Cancer Inst 97: 931\u2013935.","journal-title":"J Natl Cancer Inst"},{"key":"BFonc200914_CR55","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/modpathol.3800152","volume":"17","author":"MB Warren","year":"2004","unstructured":"Warren MB, Torres-Cabala CA, Turner ML, Merino MJ, Matrosova VY, Nickerson ML et al. (2004). Expression of Birt\u2013Hogg\u2013Dube gene mRNA in normal and neoplastic human tissues. Mod Pathol 17: 998\u20131011.","journal-title":"Mod Pathol"},{"key":"BFonc200914_CR56","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cancergencyto.2007.10.010","volume":"180","author":"Y Yang","year":"2008","unstructured":"Yang Y, Padilla-Nash HM, Vira MA, Abu-Asab MS, Val D, Worrell R et al. (2008). The UOK 257 cell line: a novel model for studies of the human Birt\u2013Hogg\u2013Dube gene pathway. Cancer Genet Cytogenet 180: 100\u2013109.","journal-title":"Cancer Genet Cytogenet"},{"key":"BFonc200914_CR57","first-page":"393","volume":"11","author":"B Zbar","year":"2002","unstructured":"Zbar B, Alvord WG, Glenn G, Turner M, Pavlovich CP, Schmidt L et al. (2002). Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt\u2013Hogg\u2013Dube syndrome. Cancer Epidemiol Biomarkers Prev 11: 393\u2013400.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFonc200914_CR58","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/ncb999","volume":"5","author":"Y Zhang","year":"2003","unstructured":"Zhang Y, Gao X, Saucedo LJ, Ru B, Edgar BA, Pan D . (2003). Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat Cell Biol 5: 578\u2013581.","journal-title":"Nat Cell Biol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc200914.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc200914","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc200914.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T12:19:08Z","timestamp":1647865148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc200914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,23]]},"references-count":58,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2009,4,2]]}},"alternative-id":["BFonc200914"],"URL":"https:\/\/doi.org\/10.1038\/onc.2009.14","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,23]]},"assertion":[{"value":"9 October 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}